Proteins and Peptides
3 December 2013
Biotest-EpiVax Collaborative Research Targets New, Non-Immunogenic Treatment for Hemophilia A3 December 2013
Synageva BioPharma™ Completes Target Enrollment in Phase 3 ARISE Trial with Sebelipase Alfa in Children and Adults with LAL Deficiency2 December 2013
Polaris Group Files New IND for ADI-PEG 20 in Leukemia27 November 2013
Durata Therapeutics Announces FDA’s Acceptance for Priority Review of NDA for Dalvance(TM) (dalbavancin hydrochloride)25 November 2013
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy21 November 2013
European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company’s Fibrocaps Hemostatic Agent20 November 2013
FDA Advisory Committee Recommends Approval for BioMarin’s Vimizim(TM) for the Treatment of Patients With Morquio A Syndrome18 November 2013
Teva Announces Updates to Oncology Biologic Portfolio18 November 2013
NovoEight® passed the review by the Committee on Drugs of Pharmaceutical Affairs in Japan14 November 2013
Lilly Announces Significant Global Insulin Manufacturing Capacity Investments in Response to Growing Diabetes Epidemic14 November 2013
Adocia announces the initiation of a clinical trial on its combination of the long-acting insulin Glargine and a fast-acting insulin analog13 November 2013
NPS Pharmaceuticals Announces FDA Acceptance of Supplemental New Drug Application for Gattex® (Teduglutide [rDNA origin]) for Injection13 November 2013
Baxter Completes Enrollment in Phase III Clinical Trial of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A13 November 2013
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Chronic Idiopathic Constipation13 November 2013
Discovery Labs Receives FDA Clearance of IND to Initiate AEROSURF® Phase 2 Clinical Program11 November 2013
ERYTECH Announces Positive DSMB Review of its Phase IIb Study in Acute Myeloid LeukemiaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports